2007
DOI: 10.1016/j.jpeds.2007.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Effect of 1-Desamino-8-D-Arginine Vasopressin on Prepulse Inhibition of Startle Supports a Central Etiology of Primary Monosymptomatic Enuresis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0
1

Year Published

2009
2009
2014
2014

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(22 citation statements)
references
References 15 publications
0
21
0
1
Order By: Relevance
“…SchulzJuergensen et al [13] previously showed that dDAVP strengthens reduced PPI. Our study indicates that children with nmE and reduced PPI probably benefit from dDAVP, not because of a reduction in the volume of urine produced, but rather by improved central reflex control.…”
Section: Discussionmentioning
confidence: 96%
“…SchulzJuergensen et al [13] previously showed that dDAVP strengthens reduced PPI. Our study indicates that children with nmE and reduced PPI probably benefit from dDAVP, not because of a reduction in the volume of urine produced, but rather by improved central reflex control.…”
Section: Discussionmentioning
confidence: 96%
“…On the contrary, desmopressin may have effects on arousal and central nervous functions as well as the well known antidiuretic properties [35 ]. Maybe its antienuretic properties do not only reside in the reduction of urine output.…”
Section: Sleep-directed and Central Nervous System-directed Treatmentmentioning
confidence: 99%
“…The described association of the number of AVPR1A promoter repeats and PPI [11] and the effect of dDAVP on PPI in nocturnal enuresis [14] therefore strongly suggested genetic variations of the AVPR1a receptor as pathogenetic factors in nocturnal enuresis.…”
Section: Discussionmentioning
confidence: 96%
“…In this context, patients with nocturnal enuresis (NE) represent an interesting group with a specific phenotype: a large proportion has been repeatedly shown to have reduced PPI [12] [13], and show both clinical improvement as well as improvement of PPI through desamino arginine vasopressin (dDAVP) [14], suggesting an effect of dDAVP on central reflex control via the central AVP-receptor AVPR1a.…”
Section: Introductionmentioning
confidence: 99%